ScholarIQanswers from OpenAlex
Josep Carreras Leukaemia Research Institute
InstitutionResearch output, impact & collaborations
Josep Carreras Leukaemia Research Institute is a institution indexed in ScholarIQ from OpenAlex.
What is known about Josep Carreras Leukaemia Research Institute?
ScholarIQrecord summary
Josep Carreras Leukaemia Research Institute is a research organisation in Barcelona, ES. OpenAlex records 2,878 works and 152,819 citations for it. 676 researchers list it as their most recent affiliation.
How many works does Josep Carreras Leukaemia Research Institute have?
ScholarIQindexed works
Josep Carreras Leukaemia Research Institute has 2,878 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Josep Carreras Leukaemia Research Institute have?
ScholarIQcitation count
Josep Carreras Leukaemia Research Institute has 152,819 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Josep Carreras Leukaemia Research Institute?
ScholarIQresearcher count
Josep Carreras Leukaemia Research Institute has 676 researchers in the ScholarIQ index.
What is the average h-index at Josep Carreras Leukaemia Research Institute?
ScholarIQavg h-index
Josep Carreras Leukaemia Research Institute has an average h-index of 54.4 in OpenAlex.
What is the ROR of Josep Carreras Leukaemia Research Institute?
ScholarIQror
The ROR for Josep Carreras Leukaemia Research Institute is on the source record.
What is the OpenAlex record for Josep Carreras Leukaemia Research Institute?
ScholarIQopenalex
The OpenAlex for Josep Carreras Leukaemia Research Institute is on the source record.
Who are the most-cited researchers behind Josep Carreras Leukaemia Research Institute?
ScholarIQtop researchers by citations
What are the most-cited papers on Josep Carreras Leukaemia Research Institute?
ScholarIQmost cited works
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel
Teclistamab in Relapsed or Refractory Multiple Myeloma
Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk, Hareth Nahi, Jesús F. San Miguel, Albert Oriol, Ajay K. Nooka, Thomas G. Martin, Laura Rosiñol, Ajai Chari, Lionel Karlin, Lotfi Benboubker, María‐Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez‐López, Surbhi Sidana, Michel Delforge, Lixia Pei, Danielle Trancucci, Raluca Verona, Suzette Girgis, Shun Xin Wang Lin, Yunsi Olyslager, Mindy Jaffe, Clarissa Uhlar, Tara Stephenson, Rian Van Rampelbergh, Arnob Banerjee, Jenna D. Goldberg, Rachel Kobos, Amrita Krishnan, Saad Z. Usmani
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Amaia Lujambio, Santiago Ropero, Esteban Ballestar, Mario F. Fraga, Celia Cerrato, Fernando Setién, Sara Casado, Ana Suárez‐Gauthier, Montse Sánchez‐Céspedes, Anna Gitt, Inmaculada Spiteri, Partha Pratim Das, Carlos Caldas, Eric A. Miska, Manel Esteller
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
Lotfi Benboubker, Meletios Α. Dimopoulos, Angela Dispenzieri, John Catalano, Andrew R. Belch, Michèle Cavo, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie Cavenagh, Catarina Geraldes, Je‐Jung Lee, Christine Chen, Albert Oriol, Javier de la Rubia, Lugui Qiu, Darrell White, Daniel Binder, Kenneth Anderson, Jean-Paul Fermand, Philippe Moreau, Michel Attal, Robert Knight, Guang Chen, Jason Van Oostendorp, Christian Jacques, Annette Ervin‐Haynes, Hervé Avet‐Loiseau, Cyrille Hulin, Thierry Façon
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
Ajai Chari, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez‐Otero, Elham Askari, María‐Victoria Mateos, Luciano J. Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B. Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi Hilder, Jeffery S. Russell, Jenna D. Goldberg, Amrita Krishnan
How much of the research on Josep Carreras Leukaemia Research Institute is open access?
ScholarIQopen access share
88%OPEN ACCESS